Passage Bio Inc Stock News
$3.98
14.88%
Nasdaq, Nov 06, 04:00 pm EST.
Closed.
Passage Bio Inc Stock News
Combined company to operate as Remix Therapeutics and advance Remix's pipeline of novel small molecule therapies designed to reprogram RNA processing and address disease drivers at their origin
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
